Publications

Evaluation of FASTPlaqueTB to diagnose smear-negative tuberculosis in a peripheral clinic in Kenya.

Abstract

OBJECTIVE: To evaluate the performance and feasibility of FASTPlaqueTB in smear-negative tuberculosis (TB) suspects in a peripheral clinic after laboratory upgrading.

Bonnet M Gagnidze L Varaine F Ramsay A Githui W Guerin PJ
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009 Sep ; 13(9); 1112-8. doi: . Epub 2009 12 03

Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis.

Abstract

Two new rotavirus vaccines have recently been licensed in many countries. However, their efficacy has only been shown against certain serotypes commonly circulating in Europe, North America, and Latin America, but thought to be globally important.

Sanchez-Padilla E Grais RF Guerin PJ Steele AD Burny ME Luquero FJ
The Lancet. Infectious diseases 2009 Sep ; 9(9); 567-76. doi: 10.1016/S1473-3099(09)70179-3. Epub 2009 09 07

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.

Abstract

BACKGROUND: Artesunate and amodiaquine (AS&AQ) is at present the world's second most widely used artemisinin-based combination therapy (ACT).

Zwang J Olliaro P Barennes H Bonnet M Brasseur P Bukirwa H Cohuet S D'Alessandro U Djimdé A Karema C Guthmann JP Hamour S Ndiaye JL Mårtensson A Rwagacondo C Sagara I Same-Ekobo A Sirima SB van den Broek I Yeka A Taylor WR Dorsey G Randrianarivelojosia M
Malaria journal 2009 Aug 23; 8 203. doi: 10.1186/1475-2875-8-203. Epub 2009 08 23

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.

Abstract

BACKGROUND: Very few data on anti-malarial efficacy are available from the Democratic Republic of Congo (DRC). DRC changed its anti-malarial treatment policy to amodiaquine (AQ) and artesunate (AS) in 2005.

Bonnet M Broek Iv van Herp M Urrutia PP van Overmeir C Kyomuhendo J Ndosimao CN Ashley E Guthmann JP
Malaria journal 2009 Aug 10; 8 192. doi: 10.1186/1475-2875-8-192. Epub 2009 08 10

Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method.

Abstract

BACKGROUND: Until the 1970s the prevalence of non-venereal trepanomatosis, including yaws, was greatly reduced after worldwide mass treatment. In 2005, cases were again reported in the Democratic Republic of the Congo.

Gerstl S Kiwila G Dhorda M Lonlas S Myatt M Ilunga BK Lemasson D Szumilin E Guerin PJ Ferradini L
PloS one 2009 Jul 22; 4(7); e6338. doi: 10.1371/journal.pone.0006338. Epub 2009 07 22

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

Abstract

BACKGROUND: Human African trypanosomiasis (HAT; sleeping sickness) caused by Trypanosoma brucei gambiense is a fatal disease. Current treatment options for patients with second-stage disease are toxic, ineffective, or impractical.

Priotto G Kasparian S Mutombo W Ngouama D Ghorashian S Arnold U Ghabri S Baudin E Buard V Kazadi-Kyanza S Ilunga M Mutangala W Pohlig G Schmid C Karunakara U Torreele E Kande V
Lancet (London, England) 2009 Jul 04; 374(9683); 56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 06 24

Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.

Abstract

Although multidrug-resistant (MDR) tuberculosis (TB) is a major public health problem in Eastern Europe, the factors contributing to emergence, spread and containment of MDR-TB are not well defined.

Pardini M Niemann S Varaine F Iona E Meacci F Orrù G Yesilkaya H Jarosz T Andrew P Barer M Checchi F Rinder H Orefici G Rüsch-Gerdes S Fattorini L Oggioni MR Bonnet M
Tuberculosis (Edinburgh, Scotland) 2009 Jul ; 89(4); 317-24. doi: 10.1016/j.tube.2009.04.002. Epub 2009 06 17

Prevalence of Buruli ulcer in Akonolinga health district, Cameroon: results of a cross sectional survey.

Abstract

BACKGROUND: Buruli ulcer (BU) is a chronic, indolent necrotizing disease of the skin and underlying tissues caused by Mycobacterium ulcerans, which may result in functional incapacity.

Porten K Sailor K Comte E Njikap A Sobry A Sihom F Meva'a A Eyangoh S Myatt M Nackers F Grais RF
PLoS neglected tropical diseases 2009 Jun 23; 3(6); e466. doi: 10.1371/journal.pntd.0000466. Epub 2009 06 23

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

Abstract

BACKGROUND: Little is known about immunovirological treatment outcomes and adherence in HIV/AIDS patients on antiretroviral therapy (ART) treated using a simplified management approach in rural areas of developing countries, or about t

Ahoua L Guenther G Pinoges L Anguzu P Chaix ML Le Tiec C Balkan S Olson D Olaro C Pujades-Rodríguez M
BMC infectious diseases 2009 Jun 03; 9 81. doi: 10.1186/1471-2334-9-81. Epub 2009 06 03